Accretion Pharmaceuticals (NSE:ACCPL) Total Receivables: ₹279.4 Mil (As of Mar. 2026)


NSE:ACCPL Accretion Pharmaceuticals Ltd NSE:ACCPL
18 GF Score
Price ₹154.00
! 6 Warning Signs
View Full Analysis

What is Accretion Pharmaceuticals Total Receivables?

Accretion Pharmaceuticals NSE:ACCPL -3.14% 18 Total Receivables is ₹279.4 Mil as of Mar. 2026. GuruFocus rates NSE:ACCPL with a GF Score™ of 18/100. The stock has 6 warning signs investors should review.

Accretion Pharmaceuticals's Total Receivables for the quarter that ended in Mar. 2026 was ₹279.4 Mil.

Accretion Pharmaceuticals Total Receivables Related Terms

Accretion Pharmaceuticals Total Receivables Historical Data

* Premium members only.

The historical data trend for Accretion Pharmaceuticals's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Accretion Pharmaceuticals Total Receivables Chart

Accretion Pharmaceuticals Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
Total Receivables
40.68 57.99 59.63 0.00 279.41

Accretion Pharmaceuticals Semi-Annual Data
Mar22 Mar23 Mar24 Sep24 Mar25 Sep25 Mar26
Total Receivables Get a 7-Day Free Trial 59.63 0.00 0.00 241.62 279.41
NSE:ACCPL
18GF Score
Accretion Pharmaceuticals Ltd NSE:ACCPL
Total Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Accretion Pharmaceuticals Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Frequently Asked Questions Learn more about Total Receivables →
What does a Total Receivables of ₹279.4 Mil mean?
Accretion Pharmaceuticals (NSE:ACCPL) has a Total Receivables of ₹279.4 Mil as of Mar. 2026. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Accretion Pharmaceuticals and its competitors.
Is Accretion Pharmaceuticals' Total Receivables too high?
Accretion Pharmaceuticals' current Total Receivables is ₹279.4 Mil. Overall, Accretion Pharmaceuticals has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Accretion Pharmaceuticals' Total Receivables compare to LLY and JNJ?
Accretion Pharmaceuticals' Total Receivables of ₹279.4 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Receivables for a Drug Manufacturers company?
A good Total Receivables depends on the Drug Manufacturers industry context. However, Total Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Receivables mean?
A high Total Receivables can signal that a stock is expensive relative to its fundamentals. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Accretion Pharmaceuticals and its competitors. Accretion Pharmaceuticals's current Total Receivables is ₹279.4 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Accretion Pharmaceuticals stock overvalued right now?
Accretion Pharmaceuticals (NSE:ACCPL) has a current Total Receivables of ₹279.4 Mil. The current Total Receivables is ₹279.4 Mil. Accretion Pharmaceuticals' overall GF Score™ is 18/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Receivables calculated?
Total Receivables is calculated from a company's financial statements. For Accretion Pharmaceuticals (NSE:ACCPL), the current Total Receivables is ₹279.4 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Accretion Pharmaceuticals Business Description

Address 29, Xcelon Industrial Park-1, Behind Intas Pharmaceuticals, Vasna-Chacharwadi, Ta - Sanand District, Ahmedabad, GJ, IND, 382213
Accretion Pharmaceuticals Ltd is engaged in the manufacturing of Medicinal & Pharmaceutical Products. The company manufactures tablets, oral liquid, capsule, cream, ointment, mouthwash, dusting powder, gel, ear drops, lotion, shampoo, powder, syrup, among others.
18GF Score

Get the complete analysis for NSE:ACCPL

Total Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹154.00
Price